ESR1 and breast cancer: siRNA silencing of GDPD5 reduced the viability (Figure 7C) and migration (Figure 7D) of ER + MCF-7 breast cancer cells, and decreased the migration and invasion of triple-negative MDA-MB-231 breast cancer cells (163).